"Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractiona" by Michael Chuong

Menu

Skip to main content

All Publications

Michael Chuong, Miami Cancer InstituteFollow

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial

Publication Date

9-1-2022

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

JAMA Oncol (2022) 8(9):1263-1270

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS